Health Canada approves first clinical trials of COVID-19 vaccine
In his Saturday morning press conference, Prime Minister Justin Trudeau announced that Health Canada has approved the first clinical trials of a COVID-19 vaccine. While clinical trials are ongoing in other countries, this marks the first time that Canada is dipping its toes.
The trials will go down at the Canadian Centre for Vaccinology at Dalhousie University. Basically, the National Research Council is teaming up with a biotech company that has developed a promising vaccine. So promising, in fact, that it is one of only a handful in the world approved for human testing.
PM Trudeau’s Saturday update on federal response to #COVID19:
—Health Canada approves first Cdn clinical trials for potential vaccine
—Canada Child Benefit to increase in July for upcoming year
—up to $100M for Canadian Red Cross to address COVID-19 & future floods, wildfires pic.twitter.com/SIIHHaZBm4
— CPAC (@CPAC_TV) May 16, 2020
The move was originally announced earlier this week. But, it was only today that Health Canada gave it the green light. We’re guessing that it will be a voluntary trial, but we’re waiting on an official press release.
The endgame here is ensuring that Canada is properly funding vaccine research and development. Then, should we (or another country/corporation) be successful, there will already be the infrastructure to manufacture the vaccine without external aid.
In a nutshell, Canada is hedging its bet that a vaccine will be developed by throwing our own hat in the ring. Well, we’ve got a pretty good track record when it comes to world-changing discoveries, so…